Move to topTop
October 10, 2017

TOKYO, JAPAN - October 10, 2017 - Terumo Corporation (TSE: 4543) today provided an update on the impact to its manufacturing as a result of Hurricane Maria.

In the aftermath of Hurricane Maria, Terumo has been working diligently to assess the impact to its operations in Caguas, Puerto Rico, where Terumo manufactures the Angio-Seal™ Vascular Closure product line. The safety of 261 Terumo associates and their families located on the island remains Terumo's top priority. As of October 6, Terumo has accounted for 100% of the associates. Terumo's outreach to them is ongoing and Terumo is providing relief assistance to them.

Terumo has been suspending its manufacturing since September 20. The facility sustained minimal structural damage and Terumo is in the process of making repairs. Terumo is doing everything possible to return to normal operations and provide the Angio-Seal™ family of products to its customers and patients.

The impact of the disaster on Terumo's business performance is being examined. Further details regarding the impact will be disclosed, as needed, once the analysis is completed.

About Terumo

Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 28,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.


Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.